NCI Director Dr. Ned Sharpless discusses how NCI is retooling a grant mechanism, called the MERIT R37 Award, to help early-stage investigators by extending the length of time they can receive funding under their first independent NIH grant.
from Cancer via ola Kala on Inoreader http://ift.tt/2C2c4fQ
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου